SPO Global Inc
OTC:SPOM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SPO Global Inc
Gross Profit
SPO Global Inc
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SPO Global Inc
OTC:SPOM
|
Gross Profit
$261k
|
CAGR 3-Years
197%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Gross Profit
$2.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
25%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Gross Profit
$778.8m
|
CAGR 3-Years
32%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Gross Profit
$514.5m
|
CAGR 3-Years
19%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Gross Profit
$508m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Gross Profit
$751.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SPO Global Inc
Glance View
SPO Global, Inc. engages in the development of microprocessor technologies for use in portable monitoring devices. The company is headquartered in Woodland Hills, California. The firm is focused on holding interests in emerging young businesses, and provide financing, advice and guidance to the companies. The Company’s subsidiary is Gerpang Healthcare Company, which is located in Jinan Pharma Valley Industrial Park, High-tech District. Gerpang Healthcare Company main business scope includes bio-pharmaceutical research and development (R&D), development and sales of medical information software, medical high-tech introduction, production and sales of medical supplies, dietary supplement, medicine, as well as agents and sales of medical equipment supplies.
See Also
What is SPO Global Inc's Gross Profit?
Gross Profit
261k
USD
Based on the financial report for Mar 31, 2015, SPO Global Inc's Gross Profit amounts to 261k USD.
What is SPO Global Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
39%
Over the last year, the Gross Profit growth was 67%. The average annual Gross Profit growth rates for SPO Global Inc have been 197% over the past three years , 39% over the past five years .
